Trial intelligence / Profile preview

Potassium citrate sustained-release tablets in hypocitraturia-related upper urinary tract stones

CTR20160788Phase 4Active

Sponsor
Livzon Pharmaceutical Group Inc.
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of potassium citrate in distal renal tubular acidosis (dRTA), nephrolithiasis, uric acid lithiasis, sponsored by Livzon Pharmaceutical Group Inc.. Started Apr 2017; status: active.

02

Drugs

potassium citrate
03

Conditions

distal renal tubular acidosis (dRTA)nephrolithiasisuric acid lithiasis

Beyond the preview

Go deeper on CTR20160788.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160788.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call